baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Genetic Technologies Ltd/ US37185R4065 /

13/05/2024 21:59:52	Chg. -	Volume	Bid16:51:43	Ask15:35:27	High	Low
2.44USD	-	138 Turnover: 244	2.36Bid Size: 1	2.50Ask Size: 1	2.44	2.44

GlobeNewswire 14:30 Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 14:05 Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 13:30 Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML

GlobeNewswire 13:30 BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...

GlobeNewswire 13:30 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update

GlobeNewswire 13:30 Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics

GlobeNewswire 13:00 ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabl...

GlobeNewswire 13/05 Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

Newsfile Corp 13/05 One of 2024's Must Read Memoirs About the Life of a Mother, Wife, and Caregiver Is 'Notes from a Bla...

GlobeNewswire 13/05 Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround...

GlobeNewswire 13/05 Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

GlobeNewswire 13/05 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...

GlobeNewswire 13/05 Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Ad...

GlobeNewswire 10/05 Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024

GlobeNewswire 10/05 Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 10/05 Axovia Therapeutics Announces Presentation of Preclinical Data Supporting Lead Program AXV-101 for T...

GlobeNewswire 09/05 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 09/05 Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire 09/05 Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting

GlobeNewswire 09/05 Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer

GlobeNewswire 09/05 Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the AS...

GlobeNewswire 09/05 Arbor Biotechnologies Presents Data Supporting Clinical Development of ABO-101 and Robust Potential ...

GlobeNewswire 08/05 Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly...

GlobeNewswire 08/05 Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

GlobeNewswire 08/05 Arbor Biotechnologies Announces Acquisition of Serendipity

Genetic Technologies Ltd/ US37185R4065 /

If you wish to receive reply to your feedback, please provide your email address.